Amorcyte’s Strategy for Successful Development and Commercialization
Amorcyte is committed to developing effective stem cell-based therapies for cardiovascular diseases.
For more details about AMR-001, please contact .
As part of its corporate development strategy, Amorcyte continues to seek strategic collaborations and funding opportunities.
For more details about investment and/or collaboration opportunities with Amorcyte, Inc., please email or call 201.883.5303.
|
